

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 6.43129307 |
| 2 | microglial cell activation (GO:0001774) | 5.66254952 |
| 3 | protein K11-linked deubiquitination (GO:0035871) | 5.29737297 |
| 4 | establishment of protein localization to Golgi (GO:0072600) | 5.26153433 |
| 5 | protein targeting to Golgi (GO:0000042) | 5.06440207 |
| 6 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.99309805 |
| 7 | histone H3-K36 demethylation (GO:0070544) | 4.83645375 |
| 8 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.82645167 |
| 9 | histone mRNA catabolic process (GO:0071044) | 4.73781417 |
| 10 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.71759287 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.70066519 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.70066519 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.70066519 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.70066519 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.70066519 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.70066519 |
| 17 | neural tube formation (GO:0001841) | 4.48375011 |
| 18 | histone H3-K9 demethylation (GO:0033169) | 4.31249400 |
| 19 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.26668928 |
| 20 | negative regulation of complement activation (GO:0045916) | 4.24223932 |
| 21 | macrophage activation (GO:0042116) | 4.09874329 |
| 22 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.08866813 |
| 23 | myeloid leukocyte mediated immunity (GO:0002444) | 4.07271155 |
| 24 | synapsis (GO:0007129) | 4.06446201 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02990999 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 4.01886188 |
| 27 | hepatocyte apoptotic process (GO:0097284) | 3.99912529 |
| 28 | protein K48-linked deubiquitination (GO:0071108) | 3.95773433 |
| 29 | male meiosis I (GO:0007141) | 3.94928514 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.80079528 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.79620724 |
| 32 | cellular response to ethanol (GO:0071361) | 3.78210368 |
| 33 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.77930420 |
| 34 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.77535376 |
| 35 | negative regulation of protein activation cascade (GO:2000258) | 3.70090626 |
| 36 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.70058358 |
| 37 | negative regulation of B cell mediated immunity (GO:0002713) | 3.68933348 |
| 38 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.68933348 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.65102230 |
| 40 | piRNA metabolic process (GO:0034587) | 3.61654839 |
| 41 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.51200059 |
| 42 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.49623111 |
| 43 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.49623111 |
| 44 | protein K63-linked deubiquitination (GO:0070536) | 3.47269511 |
| 45 | negative regulation of B cell proliferation (GO:0030889) | 3.42390057 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41713264 |
| 47 | response to host immune response (GO:0052572) | 3.41713264 |
| 48 | negative regulation of humoral immune response (GO:0002921) | 3.41062876 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.36599733 |
| 50 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.35080589 |
| 51 | early endosome to late endosome transport (GO:0045022) | 3.34635347 |
| 52 | protein localization to Golgi apparatus (GO:0034067) | 3.33462356 |
| 53 | macroautophagy (GO:0016236) | 3.30283244 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.25372418 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.25372418 |
| 56 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22501585 |
| 57 | protein targeting to vacuole (GO:0006623) | 3.19560801 |
| 58 | protein targeting to lysosome (GO:0006622) | 3.19560801 |
| 59 | establishment of protein localization to vacuole (GO:0072666) | 3.19560801 |
| 60 | iron ion import (GO:0097286) | 3.18764528 |
| 61 | chromosome organization involved in meiosis (GO:0070192) | 3.13808604 |
| 62 | histone H3-K4 trimethylation (GO:0080182) | 3.12516233 |
| 63 | phospholipid homeostasis (GO:0055091) | 3.11946230 |
| 64 | interkinetic nuclear migration (GO:0022027) | 3.10823627 |
| 65 | regulation of beta-amyloid formation (GO:1902003) | 3.09064940 |
| 66 | response to host (GO:0075136) | 3.08192142 |
| 67 | response to host defenses (GO:0052200) | 3.08192142 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08192142 |
| 69 | detection of biotic stimulus (GO:0009595) | 3.07710536 |
| 70 | cellular extravasation (GO:0045123) | 3.07658473 |
| 71 | male meiosis (GO:0007140) | 3.06349042 |
| 72 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.04731869 |
| 73 | mitochondrion distribution (GO:0048311) | 3.04708118 |
| 74 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.02843567 |
| 75 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.00564706 |
| 76 | negative regulation of inclusion body assembly (GO:0090084) | 3.00160977 |
| 77 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.94756248 |
| 78 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93605846 |
| 79 | negative regulation of neurotransmitter transport (GO:0051589) | 2.91927179 |
| 80 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.89823710 |
| 81 | DNA methylation involved in gamete generation (GO:0043046) | 2.87952198 |
| 82 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86924668 |
| 83 | dosage compensation (GO:0007549) | 2.85577341 |
| 84 | peptidyl-lysine trimethylation (GO:0018023) | 2.83768127 |
| 85 | meiosis I (GO:0007127) | 2.82835733 |
| 86 | synaptonemal complex assembly (GO:0007130) | 2.82536808 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81427857 |
| 88 | natural killer cell activation involved in immune response (GO:0002323) | 2.80563338 |
| 89 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.77533665 |
| 90 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.77117229 |
| 91 | reciprocal meiotic recombination (GO:0007131) | 2.75213013 |
| 92 | reciprocal DNA recombination (GO:0035825) | 2.75213013 |
| 93 | histone lysine demethylation (GO:0070076) | 2.74233711 |
| 94 | leukotriene biosynthetic process (GO:0019370) | 2.73557642 |
| 95 | histone-serine phosphorylation (GO:0035404) | 2.70804725 |
| 96 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70791959 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68687847 |
| 98 | regulation of meiosis I (GO:0060631) | 2.68161301 |
| 99 | sister chromatid cohesion (GO:0007062) | 2.66989544 |
| 100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66561786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.25716591 |
| 2 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 3.02093272 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94752637 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.89231392 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.86596763 |
| 6 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.85406687 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35237289 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.35062990 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.30887941 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25950112 |
| 11 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.24361498 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.23661570 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.13214210 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.08780206 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03390919 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00090607 |
| 17 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.97977693 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.85889951 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85797326 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.84361075 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80553029 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76419029 |
| 23 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70708926 |
| 24 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.70584247 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.69897903 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68982469 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.63797649 |
| 28 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.63072389 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60067800 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59485479 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.59060710 |
| 32 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.58918956 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56897650 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56606096 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56138564 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53954925 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51590210 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49394115 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.49373803 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.48084987 |
| 41 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48084987 |
| 42 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.47791160 |
| 43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.47219415 |
| 44 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.46912143 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.44988312 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.44988312 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44782508 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44298667 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44035493 |
| 50 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.43858401 |
| 51 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.42062768 |
| 52 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.41097692 |
| 53 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.40026728 |
| 54 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.37884291 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37634271 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.36260496 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35984107 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35230618 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33969866 |
| 60 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33850498 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33708541 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.33256463 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33133146 |
| 64 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.32770341 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31735505 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31163161 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30754056 |
| 68 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.29500600 |
| 69 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28543110 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27586777 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.25937158 |
| 72 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24015859 |
| 73 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22905880 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22139010 |
| 75 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.21227641 |
| 76 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.20552337 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18200767 |
| 78 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17654528 |
| 79 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17278541 |
| 80 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15053742 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13540288 |
| 82 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13490413 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13413216 |
| 84 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13063917 |
| 85 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.12883734 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12707908 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11022181 |
| 88 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10857192 |
| 89 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.09792333 |
| 90 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08968053 |
| 91 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07096324 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06598592 |
| 93 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05618376 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.04910091 |
| 95 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04900143 |
| 96 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.04453233 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03821777 |
| 98 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02154501 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01807419 |
| 100 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01378453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 8.66351482 |
| 2 | MP0008877_abnormal_DNA_methylation | 5.85706360 |
| 3 | MP0003787_abnormal_imprinting | 4.38330987 |
| 4 | MP0008260_abnormal_autophagy | 4.23686046 |
| 5 | MP0008057_abnormal_DNA_replication | 3.85954507 |
| 6 | MP0003724_increased_susceptibility_to | 3.64522594 |
| 7 | MP0003656_abnormal_erythrocyte_physiolo | 2.62066621 |
| 8 | MP0000427_abnormal_hair_cycle | 2.37805894 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.26975348 |
| 10 | MP0004381_abnormal_hair_follicle | 2.22412083 |
| 11 | MP0000015_abnormal_ear_pigmentation | 2.18850509 |
| 12 | MP0004883_abnormal_blood_vessel | 2.15520352 |
| 13 | MP0003121_genomic_imprinting | 2.14549612 |
| 14 | MP0004484_altered_response_of | 2.14246365 |
| 15 | MP0003221_abnormal_cardiomyocyte_apopto | 2.07229436 |
| 16 | MP0002166_altered_tumor_susceptibility | 1.93148681 |
| 17 | MP0003195_calcinosis | 1.91757741 |
| 18 | MP0005310_abnormal_salivary_gland | 1.85074438 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.73047536 |
| 20 | MP0003828_pulmonary_edema | 1.70159404 |
| 21 | MP0008995_early_reproductive_senescence | 1.62956150 |
| 22 | MP0003172_abnormal_lysosome_physiology | 1.61858795 |
| 23 | MP0005075_abnormal_melanosome_morpholog | 1.58137311 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.56844482 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.54158436 |
| 26 | MP0006054_spinal_hemorrhage | 1.39966301 |
| 27 | MP0000383_abnormal_hair_follicle | 1.39641676 |
| 28 | MP0005164_abnormal_response_to | 1.37147763 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.36522416 |
| 30 | MP0001800_abnormal_humoral_immune | 1.31376953 |
| 31 | MP0000371_diluted_coat_color | 1.24935988 |
| 32 | MP0002006_tumorigenesis | 1.21472650 |
| 33 | MP0002928_abnormal_bile_duct | 1.18948778 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.17698933 |
| 35 | MP0008004_abnormal_stomach_pH | 1.16625660 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.14343496 |
| 37 | MP0001929_abnormal_gametogenesis | 1.07779390 |
| 38 | MP0002419_abnormal_innate_immunity | 1.02804019 |
| 39 | MP0000685_abnormal_immune_system | 1.01454556 |
| 40 | MP0003763_abnormal_thymus_physiology | 1.01282264 |
| 41 | MP0005376_homeostasis/metabolism_phenot | 0.99681845 |
| 42 | MP0003690_abnormal_glial_cell | 0.98871767 |
| 43 | MP0005389_reproductive_system_phenotype | 0.98729481 |
| 44 | MP0005408_hypopigmentation | 0.97292241 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 0.96521458 |
| 46 | MP0002095_abnormal_skin_pigmentation | 0.93242999 |
| 47 | MP0002723_abnormal_immune_serum | 0.92894393 |
| 48 | MP0000647_abnormal_sebaceous_gland | 0.90892772 |
| 49 | MP0003646_muscle_fatigue | 0.86915374 |
| 50 | MP0002210_abnormal_sex_determination | 0.86861076 |
| 51 | MP0003632_abnormal_nervous_system | 0.86640985 |
| 52 | MP0005266_abnormal_metabolism | 0.85735193 |
| 53 | MP0004130_abnormal_muscle_cell | 0.85141442 |
| 54 | MP0003045_fibrosis | 0.83775575 |
| 55 | MP0003698_abnormal_male_reproductive | 0.83767174 |
| 56 | MP0002009_preneoplasia | 0.83595378 |
| 57 | MP0001958_emphysema | 0.83538964 |
| 58 | MP0009785_altered_susceptibility_to | 0.83478531 |
| 59 | MP0002452_abnormal_antigen_presenting | 0.82293613 |
| 60 | MP0005451_abnormal_body_composition | 0.81425792 |
| 61 | MP0000689_abnormal_spleen_morphology | 0.80397722 |
| 62 | MP0002420_abnormal_adaptive_immunity | 0.80335286 |
| 63 | MP0001819_abnormal_immune_cell | 0.79218924 |
| 64 | MP0002405_respiratory_system_inflammati | 0.77989821 |
| 65 | MP0001119_abnormal_female_reproductive | 0.77652624 |
| 66 | MP0000653_abnormal_sex_gland | 0.77599081 |
| 67 | MP0004043_abnormal_pH_regulation | 0.75603035 |
| 68 | MP0001851_eye_inflammation | 0.75116226 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.74863797 |
| 70 | MP0002168_other_aberrant_phenotype | 0.74656759 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 0.74314686 |
| 72 | MP0002160_abnormal_reproductive_system | 0.74226649 |
| 73 | MP0003786_premature_aging | 0.73729156 |
| 74 | MP0005187_abnormal_penis_morphology | 0.73189433 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.70536334 |
| 76 | MP0001145_abnormal_male_reproductive | 0.70086343 |
| 77 | MP0010307_abnormal_tumor_latency | 0.69416889 |
| 78 | MP0002722_abnormal_immune_system | 0.69166880 |
| 79 | MP0003122_maternal_imprinting | 0.68831808 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.68405527 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.68405527 |
| 82 | MP0005025_abnormal_response_to | 0.67943432 |
| 83 | MP0008058_abnormal_DNA_repair | 0.67529283 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.66718412 |
| 85 | MP0002277_abnormal_respiratory_mucosa | 0.65846886 |
| 86 | MP0000716_abnormal_immune_system | 0.65541764 |
| 87 | MP0002102_abnormal_ear_morphology | 0.64798388 |
| 88 | MP0002398_abnormal_bone_marrow | 0.64587256 |
| 89 | MP0003303_peritoneal_inflammation | 0.64565263 |
| 90 | MP0001984_abnormal_olfaction | 0.62465921 |
| 91 | MP0002132_abnormal_respiratory_system | 0.62033858 |
| 92 | MP0009764_decreased_sensitivity_to | 0.61995090 |
| 93 | MP0003252_abnormal_bile_duct | 0.60866153 |
| 94 | MP0002163_abnormal_gland_morphology | 0.60497059 |
| 95 | MP0003091_abnormal_cell_migration | 0.60296067 |
| 96 | MP0001919_abnormal_reproductive_system | 0.59485217 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.58388320 |
| 98 | MP0005671_abnormal_response_to | 0.56109346 |
| 99 | MP0004742_abnormal_vestibular_system | 0.55269422 |
| 100 | MP0004142_abnormal_muscle_tone | 0.55016570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.66496262 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.05696790 |
| 3 | T lymphocytopenia (HP:0005403) | 3.96862802 |
| 4 | Abnormality of T cell number (HP:0011839) | 3.84091498 |
| 5 | Optic neuritis (HP:0100653) | 3.62736101 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.62736101 |
| 7 | Volvulus (HP:0002580) | 3.35420245 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 3.32644559 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.25910451 |
| 10 | Tubulointerstitial nephritis (HP:0001970) | 3.18810854 |
| 11 | Orchitis (HP:0100796) | 3.17128790 |
| 12 | Postural instability (HP:0002172) | 3.16716174 |
| 13 | Myositis (HP:0100614) | 3.08663451 |
| 14 | Peritonitis (HP:0002586) | 3.07821650 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.00137961 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 2.86953331 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 2.84877402 |
| 18 | Genetic anticipation (HP:0003743) | 2.82735561 |
| 19 | Keratoconjunctivitis (HP:0001096) | 2.74083944 |
| 20 | Gingivitis (HP:0000230) | 2.73147279 |
| 21 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.70860493 |
| 22 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.70860493 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.69717086 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 2.69717086 |
| 25 | Resting tremor (HP:0002322) | 2.65090386 |
| 26 | Gingival bleeding (HP:0000225) | 2.63590792 |
| 27 | Chronic hepatic failure (HP:0100626) | 2.63295247 |
| 28 | Febrile seizures (HP:0002373) | 2.59585936 |
| 29 | Pancreatic cysts (HP:0001737) | 2.55801253 |
| 30 | Recurrent skin infections (HP:0001581) | 2.54947915 |
| 31 | Truncal obesity (HP:0001956) | 2.50402385 |
| 32 | Widely spaced teeth (HP:0000687) | 2.48297611 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.44478963 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.44478963 |
| 35 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.44052711 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.42608236 |
| 37 | Subacute progressive viral hepatitis (HP:0006572) | 2.41595609 |
| 38 | Periodontitis (HP:0000704) | 2.40032838 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39441724 |
| 40 | Thyroiditis (HP:0100646) | 2.35989602 |
| 41 | Hip dysplasia (HP:0001385) | 2.35491424 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.35136907 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.34399308 |
| 44 | Arterial thrombosis (HP:0004420) | 2.30442492 |
| 45 | Oligodactyly (hands) (HP:0001180) | 2.29968024 |
| 46 | True hermaphroditism (HP:0010459) | 2.27226634 |
| 47 | Eczematoid dermatitis (HP:0000976) | 2.25412160 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.25304892 |
| 49 | Progressive cerebellar ataxia (HP:0002073) | 2.23769133 |
| 50 | Abnormality of the renal medulla (HP:0100957) | 2.20099154 |
| 51 | Pancreatic fibrosis (HP:0100732) | 2.19501881 |
| 52 | Abnormality of the renal cortex (HP:0011035) | 2.17892218 |
| 53 | Conjunctival telangiectasia (HP:0000524) | 2.14431203 |
| 54 | Thyroid carcinoma (HP:0002890) | 2.14013131 |
| 55 | Fair hair (HP:0002286) | 2.13873586 |
| 56 | Facial diplegia (HP:0001349) | 2.11418885 |
| 57 | Abnormality of T cells (HP:0002843) | 2.09493589 |
| 58 | Recurrent bronchitis (HP:0002837) | 2.06662920 |
| 59 | Portal hypertension (HP:0001409) | 2.06148630 |
| 60 | Nephronophthisis (HP:0000090) | 1.98806054 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98141880 |
| 62 | Hypoplasia of the thymus (HP:0000778) | 1.97347993 |
| 63 | Pelvic girdle muscle weakness (HP:0003749) | 1.96452327 |
| 64 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.92595741 |
| 65 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.92595741 |
| 66 | Abnormal ciliary motility (HP:0012262) | 1.92173142 |
| 67 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90788175 |
| 68 | Leukocytosis (HP:0001974) | 1.90047226 |
| 69 | Aqueductal stenosis (HP:0002410) | 1.89483573 |
| 70 | Abnormality of chromosome stability (HP:0003220) | 1.88016697 |
| 71 | Stomach cancer (HP:0012126) | 1.87637677 |
| 72 | Generalized hypopigmentation of hair (HP:0011358) | 1.86760048 |
| 73 | Stomatitis (HP:0010280) | 1.85762336 |
| 74 | Abnormality of the hepatic vasculature (HP:0006707) | 1.84815676 |
| 75 | Abnormality of the corticospinal tract (HP:0002492) | 1.84549288 |
| 76 | Neurodegeneration (HP:0002180) | 1.82701406 |
| 77 | Spontaneous abortion (HP:0005268) | 1.82577366 |
| 78 | Hyperventilation (HP:0002883) | 1.81532209 |
| 79 | Acute hepatic failure (HP:0006554) | 1.81292285 |
| 80 | Absent speech (HP:0001344) | 1.79856325 |
| 81 | Acute myeloid leukemia (HP:0004808) | 1.77967344 |
| 82 | Medial flaring of the eyebrow (HP:0010747) | 1.75755537 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74334556 |
| 84 | Poikilocytosis (HP:0004447) | 1.73625805 |
| 85 | Glucose intolerance (HP:0000833) | 1.73579327 |
| 86 | Progressive inability to walk (HP:0002505) | 1.73567359 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.72326177 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.72270733 |
| 89 | Keratitis (HP:0000491) | 1.72046989 |
| 90 | Tubulointerstitial abnormality (HP:0001969) | 1.72044875 |
| 91 | Gonadotropin excess (HP:0000837) | 1.71265889 |
| 92 | Visual hallucinations (HP:0002367) | 1.71175117 |
| 93 | Testicular neoplasm (HP:0010788) | 1.71059201 |
| 94 | Hyperkalemia (HP:0002153) | 1.67536910 |
| 95 | Low anterior hairline (HP:0000294) | 1.67281212 |
| 96 | Rhabdomyosarcoma (HP:0002859) | 1.66648557 |
| 97 | Hemoptysis (HP:0002105) | 1.66365084 |
| 98 | Viral hepatitis (HP:0006562) | 1.65579061 |
| 99 | Encephalitis (HP:0002383) | 1.65530407 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65281379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.38595833 |
| 2 | ACVR1B | 2.56753796 |
| 3 | BLK | 2.49888548 |
| 4 | FGR | 2.36446328 |
| 5 | PIK3CG | 2.21878975 |
| 6 | PLK2 | 2.11810815 |
| 7 | SGK2 | 2.10918937 |
| 8 | PTK2B | 2.09602006 |
| 9 | MAP3K2 | 2.07535200 |
| 10 | CAMKK2 | 2.02191234 |
| 11 | TAOK3 | 1.93022231 |
| 12 | BMPR1B | 1.87261534 |
| 13 | WNK1 | 1.86858570 |
| 14 | NLK | 1.84031941 |
| 15 | IKBKE | 1.67842391 |
| 16 | GRK6 | 1.65203206 |
| 17 | AKT3 | 1.63951247 |
| 18 | IRAK1 | 1.48215621 |
| 19 | IRAK4 | 1.48169466 |
| 20 | MAP3K6 | 1.45816684 |
| 21 | WNK3 | 1.44793172 |
| 22 | CSK | 1.40829971 |
| 23 | FGFR3 | 1.35138359 |
| 24 | PNCK | 1.34211633 |
| 25 | STK4 | 1.32971009 |
| 26 | ERBB2 | 1.29373687 |
| 27 | SGK3 | 1.29315198 |
| 28 | RIPK4 | 1.28548748 |
| 29 | GRK5 | 1.24718965 |
| 30 | MAP2K3 | 1.24137147 |
| 31 | OXSR1 | 1.23429296 |
| 32 | PAK3 | 1.23159172 |
| 33 | STK38L | 1.22409648 |
| 34 | TXK | 1.22379904 |
| 35 | JAK3 | 1.21273706 |
| 36 | MELK | 1.20811938 |
| 37 | INSRR | 1.20610972 |
| 38 | MAP3K4 | 1.19066383 |
| 39 | YES1 | 1.18808522 |
| 40 | SGK494 | 1.17283682 |
| 41 | SGK223 | 1.17283682 |
| 42 | NUAK1 | 1.17275100 |
| 43 | KSR1 | 1.16278361 |
| 44 | TEC | 1.09447044 |
| 45 | JAK1 | 1.08339055 |
| 46 | CAMK1G | 1.06340629 |
| 47 | BRD4 | 1.04631817 |
| 48 | TNIK | 0.97773392 |
| 49 | MAP4K2 | 0.96388834 |
| 50 | CDK19 | 0.94902453 |
| 51 | MAP3K5 | 0.94434682 |
| 52 | DYRK1A | 0.93739326 |
| 53 | SYK | 0.91324377 |
| 54 | BMPR2 | 0.88680607 |
| 55 | STK11 | 0.86028331 |
| 56 | NEK9 | 0.85921174 |
| 57 | IRAK2 | 0.85852707 |
| 58 | MAP2K4 | 0.84514103 |
| 59 | DYRK3 | 0.84416231 |
| 60 | JAK2 | 0.83873782 |
| 61 | SGK1 | 0.82693237 |
| 62 | TRPM7 | 0.82471731 |
| 63 | TRIM28 | 0.82357699 |
| 64 | ADRBK1 | 0.81315564 |
| 65 | BTK | 0.80547069 |
| 66 | BCR | 0.80112261 |
| 67 | TYK2 | 0.79432276 |
| 68 | EGFR | 0.77181864 |
| 69 | MARK3 | 0.76782588 |
| 70 | CAMK4 | 0.76049634 |
| 71 | PIM1 | 0.75988183 |
| 72 | FGFR2 | 0.75804168 |
| 73 | MAPK13 | 0.73180556 |
| 74 | NTRK3 | 0.71461738 |
| 75 | STK38 | 0.69771370 |
| 76 | FES | 0.69407325 |
| 77 | MARK2 | 0.67361712 |
| 78 | HCK | 0.65860523 |
| 79 | LYN | 0.63608724 |
| 80 | MUSK | 0.62552136 |
| 81 | ITK | 0.61752324 |
| 82 | CAMK1D | 0.60763499 |
| 83 | TGFBR2 | 0.60143445 |
| 84 | PINK1 | 0.58904120 |
| 85 | RET | 0.58382213 |
| 86 | RAF1 | 0.56534265 |
| 87 | MAP3K14 | 0.55140262 |
| 88 | BRSK2 | 0.53000902 |
| 89 | PRKAA2 | 0.52109031 |
| 90 | PDGFRB | 0.48740635 |
| 91 | STK39 | 0.48201163 |
| 92 | NEK6 | 0.48001300 |
| 93 | CHUK | 0.41220163 |
| 94 | LCK | 0.40977593 |
| 95 | STK24 | 0.40794979 |
| 96 | ERBB3 | 0.40332315 |
| 97 | CSF1R | 0.39346006 |
| 98 | MAP3K7 | 0.39161728 |
| 99 | PIK3CA | 0.38917195 |
| 100 | MAP3K1 | 0.38587567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.68180696 |
| 2 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.41662684 |
| 3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17424982 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84359981 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 1.74269582 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68770513 |
| 7 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.64699841 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.62426413 |
| 9 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.57677950 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.57338353 |
| 11 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.55677423 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.50811438 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47606819 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46681021 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.41098315 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.39705918 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36333517 |
| 18 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35847518 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.35574156 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30451092 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29730179 |
| 22 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27671679 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.27304259 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.25841813 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23075162 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21008235 |
| 27 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13221609 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.10538094 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05081342 |
| 30 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.04665186 |
| 31 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.04075744 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99122704 |
| 33 | Malaria_Homo sapiens_hsa05144 | 0.98614592 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95419565 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 0.94452485 |
| 36 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93038990 |
| 37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90204318 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 0.90029615 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89325514 |
| 40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.89106345 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88955007 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.85702205 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84591736 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82535434 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82160375 |
| 46 | Homologous recombination_Homo sapiens_hsa03440 | 0.81513289 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81467098 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81044987 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80943482 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80477046 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.80015896 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.78101296 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77063840 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75791308 |
| 55 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74728576 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74490688 |
| 57 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74401967 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74381393 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74122162 |
| 60 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72178070 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71614271 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70997048 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.70835906 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.70718281 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69403969 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.68960182 |
| 67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68648643 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68083010 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66424142 |
| 70 | Nicotine addiction_Homo sapiens_hsa05033 | 0.66235833 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65979186 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.65864162 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62782489 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61244683 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.60965757 |
| 76 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60266585 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60182371 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.59794166 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59687667 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.59652323 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59014993 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58395558 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58250184 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57830784 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.57436476 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56685363 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56652813 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56176179 |
| 89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55782331 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55423027 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55327129 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55156863 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54573442 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.53321111 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53312724 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.52667538 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52615185 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51616611 |
| 99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50932419 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.50846172 |

